Blog

Elizabeth Gargill

Recent Posts

Managing Patient Travel as Countries and Study Sites Reopen

Posted by Elizabeth Gargill on Wed, Jul 29, 2020

The Road to Reopening

In our newest Pharma15 Live! episode, Principal of RSG Services Rob Laurens provides guidance on managing clinical trial patient travel as COVID-19 restrictions ease and countries and study sites start to reopen.

Rob answers common questions and highlights the advantages of thoughtful pre-planning and contingency preparation. Watch now and discover strategies clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond.

 

Download the eBook

Download eBook

 

Because there's a lot to consider in terms of managing patient travel as COVID-19 restrictions ease, we've captured guidance in a special eBook to download and review at your convenience.

 

Read More

Topics: Patient Engagement, Patient Travel, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Rob Laurens

Bonus Content: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 26, 2020

More of Your Questions Answered

In this special video clip, industry innovators Aaron Fleishman and Craig Lipset answer some of the overflow questions from our Virtual Town Hall on maintaining clinical trial momentum during COVID-19 and beyond.

This 20-minute segment features answers to your questions relating to:

  • Implementation of decentralized trials
  • Impact of COVID-19 on enrollment of healthy volunteers
  • Biggest concerns for clinicians around remote contact with patients
  • Advancing decentralized trials while not leaving behind people without access to reliable internet, electronic devices, or digital savvy
  • Validating new digital endpoints for decentralized trials
  • Impact of telemedicine and other decentralized trial approaches on  monitoring and source data verification (SDV)

 

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Watch Now: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 19, 2020

Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.

Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

"COVID-19 and Beyond" Virtual Town Hall

Posted by Elizabeth Gargill on Wed, May 6, 2020

"COVID-19 and Beyond" Virtual Town Hall - May 14, 2020 @ 12:00 p.m. ET

Join industry innovators Craig Lipset and Aaron Fleishman for a virtual town hall to discuss maintaining clinical trial momentum during COVID-19 and beyond. Register now.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

What and When to Submit to the IRB?

Posted by Elizabeth Gargill on Wed, Apr 29, 2020

Insights from Advarra on Managing Changes to Patient Enrollment & Engagement due to COVID-19

Get an IRB's perspective on managing clinical trial enrollment modifications due to COVID-19 by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official, Advarra.

Read More

Topics: Patient Engagement, Pharma15 Live!, COVID-19, Clinical Trial Enrollment, Institutional Review Board, Rob Laurens, IRB

Maintaining Clinical Trial Momentum during COVID-19 and Beyond

Posted by Elizabeth Gargill on Thu, Apr 23, 2020

In our latest Pharma15 Live! COVID-19 special report, BBK's President Matt Kibby introduces a new framework for helping clinical trial sponsors maintain study momentum during COVID-19 and beyond.

The framework features strategies for minimizing disruption during four key stages of the study lifecycle.

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, Coronavirus, Matt Kibby

Ramping Up Patient & Site Engagement during COVID-19

Posted by Elizabeth Gargill on Tue, Apr 14, 2020

 

Guidance to Help Respond to Immediate Challenges 

As the COVID-19 outbreak challenges clinical trial sponsors, we’ve identified efforts to support patient and site engagement -  helping to minimize clinical trial disruption and keep timelines intact. Some efforts respond to FDA guidance on conducting clinical trials during the COVID-19 pandemic while others respond to challenges introduced by travel restrictions, infection risks, enhanced site burden, and protocol deviations.

Read More

Topics: Patient Engagement, Site Engagement, RSG Arrive, COVID-19

Minimizing Clinical Trial Disruption from COVID-19

Posted by Elizabeth Gargill on Thu, Apr 2, 2020

BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak. 

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer

5 Innovations Shaking Up Clinical Trial Patient Recruitment

Posted by Elizabeth Gargill on Tue, Mar 10, 2020

 

For clinical trial sponsors, staying on top of the latest innovations can be a challenge, especially in an industry historically slow to adapt to change. But experts warn of the risk of falling behind, especially in light of advancing technologies that are impacting clinical trial enrollment and engagement.

While you may not be ready to embrace the use of a virtual self-service hologram—greeting patients in the doctor’s office with information about a clinical trial—there are a few key innovations that all clinical trial sponsors should keep on their radar. Below, we highlight three that are driving significant change.

 

Read More

Topics: Wearables, Patient Experience, Voice Assistants, Patient Portals, Call Centers, At-home Visits, Clinical Trial Innovations

Latest “Study Voices” Survey Finds Unexpected Similarities Between Healthcare Consumers and Clinical Trial Participants

Posted by Elizabeth Gargill on Thu, Feb 20, 2020

 

Survey Results Empower Clinical Trial Sponsors with New Opportunities for Patient Engagement

Our latest "Study Voices" survey challenges the long-held belief that the clinical trial experience should be approached differently than the healthcare consumer experience. The latest “Study Voices” survey – part of an ongoing series of surveys designed to shed light on key clinical research trends – explores patient attitudes towards technology,  healthcare affordability, physician access, transparency, and quality of care. It features responses from 2,067 individuals – 63% of whom identify themselves as healthcare consumers and 38% of whom identify themselves as clinical trial participants. The research was spearheaded by BBK's MythBusters team of Aaron Fleishman, Matt Kibby, Jessica Kim, Maddy Johnson and Elizabeth Gargill.

Read More

Topics: Study Voices, MythBusters, Healthcare Consumer, Clinical Trial Participant